MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$86,089,779
Cash and cash
equivalents
$10,502,680
Prepaid expenses and
other current assets
$3,513,384
Accrued interest
receivable
$946,781
Total property, plant
and equipment,...
$30,822,364
Total current assets
$101,052,624
Long-term investments
$46,892,882
Property, plant and
equipment, net
$13,305,902
Long-term prepaid assets
$5,309,345
Financing lease
right-of-use assets
$3,496,012
Operating lease
right-of-use assets
$2,603,059
Deferred issuance cost
$150,145
Less accumulated
depreciation and...
$17,516,462
Total assets
$172,809,969
Total liabilities and
stockholders' equity
$172,809,969
Total stockholders'
equity
$151,494,375
Total liabilities
$21,315,594
Accumulated deficit
-$110,895,167
Treasury stock, at cost
54,665 shares held at...
$5,521,246
Additional paid-in capital
$267,719,445
Total current
liabilities
$10,681,170
Warrant liabilities
$5,635,112
Finance lease
liabilities, noncurrent
$3,121,952
Operating lease
liabilities, noncurrent
$1,877,360
Accumulated other
comprehensive income (loss)
$186,510
Common stock 0.0001 par
value 800,000,000...
$4,766
Preferred stock-Series
BPreferred Stock
$64
Preferred stock-Series
APreferred Stock
$3
Accrued expenses and
other current...
$6,583,996
Accounts payable
$3,145,805
Operating lease
liabilities, current portion
$797,402
Finance lease
liabilities, current portion
$153,967
Back
Back
Balance Sheet
source: myfinsight.com
SAB Biotherapeutics, Inc. (SABSW)
SAB Biotherapeutics, Inc. (SABSW)